Skip to main content

The Effect of New Therapeutic and Diagnostic Agents on the Prognosis of Hepatocellular Carcinoma in Japan – An Analysis of Data from the Kanagawa Cancer Registry.

Publication ,  Journal Article
Kaneko, R; Nakazaki, N; Omori, R; Yano, Y; Ogawa, M; Sato, Y
Published in: Asian Pac J Cancer Prev
September 27, 2017

Objective: Notable advances in diagnostic imaging modalities and therapeutic agents have contributed to improvement in the prognosis of hepatocellular carcinoma (HCC) over the past decade. However, knowledge concerning their epidemiological contribution remains limited. The present study investigated the effect of emerging diagnostic and therapeutic agents on HCC prognosis, using the largest regional cancer registry in Japan. Methods: Using data from the Kanagawa Cancer Registry, the five-year survival rate of patients with liver cancer was estimated according to the International Statistical Classification of Diseases and Related Health Problems (10th Edition). Result: A total of 40,276 cases of HCC (from 1976 to 2013) were identified. The prognosis markedly improved after the introduction of new devices into the diagnosis and treatment of HCC (p<0.01). The trend of survival rate varied significantly between institutions with many registered patients (high-volume centers) (p<0.01). Conclusion: The five-year survival rate of patients with HCC in Kanagawa has markedly improved in recent years. This improvement in survival may be attributed to the advances in surveillance and intervention for the treatment of HCC.

Duke Scholars

Published In

Asian Pac J Cancer Prev

DOI

EISSN

2476-762X

Publication Date

September 27, 2017

Volume

18

Issue

9

Start / End Page

2471 / 2476

Location

Thailand

Related Subject Headings

  • Oncology & Carcinogenesis
  • 4206 Public health
  • 4202 Epidemiology
  • 3211 Oncology and carcinogenesis
  • 1117 Public Health and Health Services
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kaneko, R., Nakazaki, N., Omori, R., Yano, Y., Ogawa, M., & Sato, Y. (2017). The Effect of New Therapeutic and Diagnostic Agents on the Prognosis of Hepatocellular Carcinoma in Japan – An Analysis of Data from the Kanagawa Cancer Registry. Asian Pac J Cancer Prev, 18(9), 2471–2476. https://doi.org/10.22034/APJCP.2017.18.9.2471
Kaneko, Rena, Natsuko Nakazaki, Risa Omori, Yuichiro Yano, Masazumi Ogawa, and Yuzuru Sato. “The Effect of New Therapeutic and Diagnostic Agents on the Prognosis of Hepatocellular Carcinoma in Japan – An Analysis of Data from the Kanagawa Cancer Registry.Asian Pac J Cancer Prev 18, no. 9 (September 27, 2017): 2471–76. https://doi.org/10.22034/APJCP.2017.18.9.2471.
Kaneko, Rena, et al. “The Effect of New Therapeutic and Diagnostic Agents on the Prognosis of Hepatocellular Carcinoma in Japan – An Analysis of Data from the Kanagawa Cancer Registry.Asian Pac J Cancer Prev, vol. 18, no. 9, Sept. 2017, pp. 2471–76. Pubmed, doi:10.22034/APJCP.2017.18.9.2471.
Kaneko R, Nakazaki N, Omori R, Yano Y, Ogawa M, Sato Y. The Effect of New Therapeutic and Diagnostic Agents on the Prognosis of Hepatocellular Carcinoma in Japan – An Analysis of Data from the Kanagawa Cancer Registry. Asian Pac J Cancer Prev. 2017 Sep 27;18(9):2471–2476.

Published In

Asian Pac J Cancer Prev

DOI

EISSN

2476-762X

Publication Date

September 27, 2017

Volume

18

Issue

9

Start / End Page

2471 / 2476

Location

Thailand

Related Subject Headings

  • Oncology & Carcinogenesis
  • 4206 Public health
  • 4202 Epidemiology
  • 3211 Oncology and carcinogenesis
  • 1117 Public Health and Health Services
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences